Pain and purinergic signaling

Brain Research Reviews

Volumn 63, Issue 1-2, 2010, Pages 222-232

  Tsuda, Makoto ^a   Tozaki Saitoh, Hidetoshi ^a   Inoue, Kazuhide ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Microglia; Neuropathic pain; Purinoceptor; Spinal cord

Indexed keywords

PURINERGIC P2X RECEPTOR; PURINERGIC P2X12 RECEPTOR; PURINERGIC P2X4 RECEPTOR; PURINERGIC P2X6 RECEPTOR; PURINERGIC P2X7 RECEPTOR; PURINERGIC P2Y RECEPTOR; UNCLASSIFIED DRUG;

CELL PROLIFERATION; CHEMICAL STRUCTURE; GENE EXPRESSION PROFILING; GLIA CELL; HYPERTROPHY; MACROPHAGE; MICROGLIA; NERVE CELL; NEUROPATHIC PAIN; PATHOPHYSIOLOGY; PERIPHERAL NERVE INJURY; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; SPINAL CORD DORSAL HORN; UPREGULATION;

ANIMALS; HUMANS; MODELS, NEUROLOGICAL; NEURALGIA; PAIN; RECEPTORS, PURINERGIC;

EID: 77949778470     PISSN: 01650173     EISSN: 18726321     Source Type: Journal    
DOI: 10.1016/j.brainresrev.2009.11.003     Document Type: Review

References (114)

1. Abbracchio M.P., Burnstock G., Boeynaems J.M., Barnard E.A., Boyer J.L., Kennedy C., Knight G.E., Fumagalli M., Gachet C., Jacobson K.A., Weisman G.A. International Union of Pharmacology LVIII: update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy. Pharmacol. Rev. 2006, 58:281-341.
2. Baron R. Mechanisms of disease: neuropathic pain-a clinical perspective. Nat. Clin. Pract. Neurol. 2006, 2:95-106.
3. Barrera N.P., Ormond S.J., Henderson R.M., Murrell-Lagnado R.D., Edwardson J.M. Atomic force microscopy imaging demonstrates that P2X2 receptors are trimers but that P2X6 receptor subunits do not oligomerize. J. Biol. Chem. 2005, 280:10759-10765.
4. Boumechache M., Masin M., Edwardson J.M., Gorecki D.C., Murrell-Lagnado R. Analysis of assembly and trafficking of native P2X4 and P2X7 receptor complexes in rodent immune cells. J. Biol. Chem. 2009, 284:13446-13454.
5. Boyer J.L., Mohanram A., Camaioni E., Jacobson K.A., Harden T.K. Competitive and selective antagonism of P2Y1 receptors by N6-methyl 2'-deoxyadenosine 3',5'-bisphosphate. Br. J. Pharmacol. 1998, 124:1-3.
6. Boyer J.L., Adams M., Ravi R.G., Jacobson K.A., Harden T.K. 2-Chloro N(6)-methyl-(N)-methanocarba-2'-deoxyadenosine-3',5'-bisphosphate is a selective high affinity P2Y(1) receptor antagonist. Br. J. Pharmacol. 2002, 135:2004-2010.
7. Buell G., Lewis C., Collo G., North R.A., Surprenant A. An antagonist-insensitive P2X receptor expressed in epithelia and brain. EMBO J. 1996, 15:55-62.
8. Burnstock G. Purinergic nerves. Pharmacol. Rev. 1972, 24:509-581.
9. Burnstock G. Purinergic signalling and disorders of the central nervous system. Nat. Rev., Drug Discov. 2008, 7:575-590.
10. Casas-Pruneda G., Reyes J.P., Perez-Flores G., Perez-Cornejo P., Arreola J. Functional interactions between P2X4 and P2X7 receptors from mouse salivary epithelia. J. Physiol. 2009, 587:2887-2901.
11. Chessell I.P., Hatcher J.P., Bountra C., Michel A.D., Hughes J.P., Green P., Egerton J., Murfin M., Richardson J., Peck W.L., Grahames C.B., Casula M.A., Yiangou Y., Birch R., Anand P., Buell G.N. Disruption of the P2X7 purinoceptor gene abolishes chronic inflammatory and neuropathic pain. Pain 2005, 114:386-396.
12. Clark A.K., Gentry C., Bradbury E.J., McMahon S.B., Malcangio M. Role of spinal microglia in rat models of peripheral nerve injury and inflammation. Eur. J. Pain 2007, 11:223-230.
13. Communi D., Robaye B., Boeynaems J.M. Pharmacological characterization of the human P2Y11 receptor. Br. J. Pharmacol. 1999, 128:1199-1206.
14. Costigan M., Scholz J., Woolf C.J. Neuropathic pain: a maladaptive response of the nervous system to damage. Annu. Rev. Neurosci. 2009, 32:1-32.
15. Coull J.A., Beggs S., Boudreau D., Boivin D., Tsuda M., Inoue K., Gravel C., Salter M.W., De Koninck Y. BDNF from microglia causes the shift in neuronal anion gradient underlying neuropathic pain. Nature 2005, 438:1017-1021.
16. Davalos D., Grutzendler J., Yang G., Kim J.V., Zuo Y., Jung S., Littman D.R., Dustin M.L., Gan W.B. ATP mediates rapid microglial response to local brain injury in vivo. Nat. Neurosci. 2005, 8:752-758.
17. Ding S., Sachs F. Inactivation of P2X2 purinoceptors by divalent cations. J. Physiol. 2000, 522(Pt 2):199-214.
18. Donnelly-Roberts D.L., Namovic M.T., Surber B., Vaidyanathan S.X., Perez-Medrano A., Wang Y., Carroll W.A., Jarvis M.F. [3H]A-804598 ([3H]2-cyano-1-[(1S)-1-phenylethyl]-3-quinolin-5-ylguanidine) is a novel, potent, and selective antagonist radioligand for P2X7 receptors. Neuropharmacology 2009, 56:223-229.
19. Dunn P.M., Liu M., Zhong Y., King B.F., Burnstock G. Diinosine pentaphosphate: an antagonist which discriminates between recombinant P2X(3) and P2X(2/3) receptors and between two P2X receptors in rat sensory neurones. Br. J. Pharmacol. 2000, 130:1378-1384.
20. Echeverry S., Shi X.Q., Zhang J. Characterization of cell proliferation in rat spinal cord following peripheral nerve injury and the relationship with neuropathic pain. Pain 2008, 135:37-47.
21. Fam S.R., Gallagher C.J., Salter M.W. P2Y(1) purinoceptor-mediated Ca(2+) signaling and Ca(2+) wave propagation in dorsal spinal cord astrocytes. J. Neurosci. 2000, 20:2800-2808.
22. Farber K., Kettenmann H. Purinergic signaling and microglia. Pflugers. Arch. 2006, 452:615-621.
23. Gachet C. The platelet P2 receptors as molecular targets for old and new antiplatelet drugs. Pharmacol. Ther. 2005, 108:180-192.
24. Griffin R.S., Costigan M., Brenner G.J., Ma C.H., Scholz J., Moss A., Allchorne A.J., Stahl G.L., Woolf C.J. Complement induction in spinal cord microglia results in anaphylatoxin C5a-mediated pain hypersensitivity. J. Neurosci. 2007, 27:8699-8708.
25. Guo L.H., Guo K.T., Wendel H.P., Schluesener H.J. Combinations of TLR and NOD2 ligands stimulate rat microglial P2X4R expression. Biochem. Biophys. Res. Commun. 2006, 349:1156-1162.
26. Guo C., Masin M., Qureshi O.S., Murrell-Lagnado R.D. Evidence for functional P2X4/P2X7 heteromeric receptors. Mol. Pharmacol. 2007, 72:1447-1456.
27. Haynes S.E., Hollopeter G., Yang G., Kurpius D., Dailey M.E., Gan W.B., Julius D. The P2Y(12) receptor regulates microglial activation by extracellular nucleotides. Nat. Neurosci. 2006, 9:1512-1519.
28. Honda S., Sasaki Y., Ohsawa K., Imai Y., Nakamura Y., Inoue K., Kohsaka S. Extracellular ATP or ADP induce chemotaxis of cultured microglia through Gi/o-coupled P2Y receptors. J. Neurosci. 2001, 21:1975-1982.
29. Honore P., Donnelly-Roberts D., Namovic M.T., Hsieh G., Zhu C.Z., Mikusa J.P., Hernandez G., Zhong C., Gauvin D.M., Chandran P., Harris R., Medrano A.P., Carroll W., Marsh K., Sullivan J.P., Faltynek C.R., Jarvis M.F. A-740003 [N-(1-{[(cyanoimino)(5-quinolinylamino) methyl]amino}-2,2-dimethylpropyl)-2-(3,4-dimethoxyphenyl)acetamide], a novel and selective P2X7 receptor antagonist, dose-dependently reduces neuropathic pain in the rat. J. Pharmacol. Exp. Ther. 2006, 319:1376-1385.
30. Ikeda H., Tsuda M., Inoue K., Murase K. Long-term potentiation of neuronal excitation by neuron-glia interactions in the rat spinal dorsal horn. Eur. J. Neurosci. 2007, 25:1297-1306.
31. Ingall A.H., Dixon J., Bailey A., Coombs M.E., Cox D., McInally J.I., Hunt S.F., Kindon N.D., Teobald B.J., Willis P.A., Humphries R.G., Leff P., Clegg J.A., Smith J.A., Tomlinson W. Antagonists of the platelet P2T receptor: a novel approach to antithrombotic therapy. J. Med. Chem. 1999, 42:213-220.
32. Inoue K. Microglial activation by purines and pyrimidines. Glia 2002, 40:156-163.
33. Inoue K. The function of microglia through purinergic receptors: neuropathic pain and cytokine release. Pharmacol. Ther. 2006, 109:210-226.
34. Inoue K. Purinergic systems in microglia. Cell. Mol. Life Sci. 2008, 65:3074-3080.
35. Inoue K., Koizumi S., Tsuda M. The role of nucleotides in the neuron-glia communication responsible for the brain functions. J. Neurochem. 2007, 102:1447-1458.
36. Irino Y., Nakamura Y., Inoue K., Kohsaka S., Ohsawa K. Akt activation is involved in P2Y12 receptor-mediated chemotaxis of microglia. J. Neurosci. Res. 2008, 86:1511-1519.
37. Jarvis M.F., Burgard E.C., McGaraughty S., Honore P., Lynch K., Brennan T.J., Subieta A., Van Biesen T., Cartmell J., Bianchi B., Niforatos W., Kage K., Yu H., Mikusa J., Wismer C.T., Zhu C.Z., Chu K., Lee C.H., Stewart A.O., Polakowski J., Cox B.F., Kowaluk E., Williams M., Sullivan J., Faltynek C. A-317491, a novel potent and selective non-nucleotide antagonist of P2X3 and P2X2/3 receptors, reduces chronic inflammatory and neuropathic pain in the rat. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:17179-17184.
38. Jarvis M.F., Khakh B.S. ATP-gated P2X cation-channels. Neuropharmacology 2009, 56:208-215.
39. Ji R.R., Kawasaki Y., Zhuang Z.Y., Wen Y.R., Decosterd I. Possible role of spinal astrocytes in maintaining chronic pain sensitization: review of current evidence with focus on bFGF/JNK pathway. Neuron Glia Biol. 2006, 2:259-269.
40. Jiang Q., Guo D., Lee B.X., Van Rhee A.M., Kim Y.C., Nicholas R.A., Schachter J.B., Harden T.K., Jacobson K.A. A mutational analysis of residues essential for ligand recognition at the human P2Y1 receptor. Mol. Pharmacol. 1997, 52:499-507.
41. Jiang L.H., Kim M., Spelta V., Bo X., Surprenant A., North R.A. Subunit arrangement in P2X receptors. J. Neurosci. 2003, 23:8903-8910.
42. Jin S.X., Zhuang Z.Y., Woolf C.J., Ji R.R. p38 mitogen-activated protein kinase is activated after a spinal nerve ligation in spinal cord microglia and dorsal root ganglion neurons and contributes to the generation of neuropathic pain. J. Neurosci. 2003, 23:4017-4022.
43. Kanazawa H., Ohsawa K., Sasaki Y., Kohsaka S., Imai Y. Macrophage/microglia-specific protein Iba1 enhances membrane ruffling and Rac activation via phospholipase C-gamma-dependent pathway. J. Biol. Chem. 2002, 277:20026-20032.
44. Katsura H., Obata K., Miyoshi K., Kondo T., Yamanaka H., Kobayashi K., Dai Y., Fukuoka T., Sakagami M., Noguchi K. Transforming growth factor-activated kinase 1 induced in spinal astrocytes contributes to mechanical hypersensitivity after nerve injury. Glia 2008, 56:723-733.
45. Kawasaki Y., Xu Z.Z., Wang X., Park J.Y., Zhuang Z.Y., Tan P.H., Gao Y.J., Roy K., Corfas G., Lo E.H., Ji R.R. Distinct roles of matrix metalloproteases in the early- and late-phase development of neuropathic pain. Nat. Med. 2008, 14:331-336.
46. Kawasaki Y., Zhang L., Cheng J.K., Ji R.R. Cytokine mechanisms of central sensitization: distinct and overlapping role of interleukin-1beta, interleukin-6, and tumor necrosis factor-alpha in regulating synaptic and neuronal activity in the superficial spinal cord. J. Neurosci. 2008, 28:5189-5194.
47. Kawate T., Michel J.C., Birdsong W.T., Gouaux E. Crystal structure of the ATP-gated P2X(4) ion channel in the closed state. Nature 2009, 460:592-598.
48. Keller A.F., Beggs S., Salter M.W., De Koninck Y. Transformation of the output of spinal lamina I neurons after nerve injury and microglia stimulation underlying neuropathic pain. Mol. Pain. 2007, 3:27.
49. Khakh B.S., Burnstock G., Kennedy C., King B.F., North R.A., Seguela P., Voigt M., Humphrey P.P. International Union of Pharmacology XXIV. Current status of the nomenclature and properties of P2X receptors and their subunits. Pharmacol. Rev. 2001, 53:107-118.
50. Kim M., Yoo O.J., Choe S. Molecular assembly of the extracellular domain of P2X2, an ATP-gated ion channel. Biochem. Biophys. Res. Commun. 1997, 240:618-622.
51. Kim H.S., Ohno M., Xu B., Kim H.O., Choi Y., Ji X.D., Maddileti S., Marquez V.E., Harden T.K., Jacobson K.A. 2-Substitution of adenine nucleotide analogues containing a bicyclo[3.1.0]hexane ring system locked in a northern conformation: enhanced potency as P2Y1 receptor antagonists. J. Med. Chem. 2003, 46:4974-4987.
52. King B.F., Liu M., Pintor J., Gualix J., Miras-Portugal M.T., Burnstock G. Diinosine pentaphosphate (IP5I) is a potent antagonist at recombinant rat P2X1 receptors. Br. J. Pharmacol. 1999, 128:981-988.
53. King B.F., Townsend-Nicholson A., Wildman S.S., Thomas T., Spyer K.M., Burnstock G. Coexpression of rat P2X2 and P2X6 subunits in Xenopus oocytes. J. Neurosci. 2000, 20:4871-4877.
54. Kobayashi K., Fukuoka T., Yamanaka H., Dai Y., Obata K., Tokunaga A., Noguchi K. Neurons and glial cells differentially express P2Y receptor mRNAs in the rat dorsal root ganglion and spinal cord. J. Comp. Neurol. 2006, 498:443-454.
55. Kobayashi K., Yamanaka H., Fukuoka T., Dai Y., Obata K., Noguchi K. P2Y12 receptor upregulation in activated microglia is a gateway of p38 signaling and neuropathic pain. J. Neurosci. 2008, 28:2892-2902.
56. Koizumi S., Shigemoto-Mogami Y., Nasu-Tada K., Shinozaki Y., Ohsawa K., Tsuda M., Joshi B.V., Jacobson K.A., Kohsaka S., Inoue K. UDP acting at P2Y6 receptors is a mediator of microglial phagocytosis. Nature 2007, 446:1091-1095.
57. Kurpius D., Nolley E.P., Dailey M.E. Purines induce directed migration and rapid homing of microglia to injured pyramidal neurons in developing hippocampus. Glia 2007, 55:873-884.
58. Le K.T., Babinski K., Seguela P. Central P2X4 and P2X6 channel subunits coassemble into a novel heteromeric ATP receptor. J. Neurosci. 1998, 18:7152-7159.
59. Lewis C., Neidhart S., Holy C., North R.A., Buell G., Surprenant A. Coexpression of P2X2 and P2X3 receptor subunits can account for ATP-gated currents in sensory neurons. Nature 1995, 377:432-435.
60. Liao Z., Seye C.I., Weisman G.A., Erb L. The P2Y2 nucleotide receptor requires interaction with alpha v integrins to access and activate G12. J. Cell. Sci. 2007, 120:1654-1662.
61. Lustig K.D., Shiau A.K., Brake A.J., Julius D. Expression cloning of an ATP receptor from mouse neuroblastoma cells. Proc. Natl. Acad. Sci. U. S. A. 1993, 90:5113-5117.
62. Mamedova L.K., Joshi B.V., Gao Z.G., von Kugelgen I., Jacobson K.A. Diisothiocyanate derivatives as potent, insurmountable antagonists of P2Y6 nucleotide receptors. Biochem. Pharmacol. 2004, 67:1763-1770.
63. Marchand F., Perretti M., McMahon S.B. Role of the immune system in chronic pain. Nat. Rev., Neurosci. 2005, 6:521-532.
64. McGaraughty S., Chu K.L., Namovic M.T., Donnelly-Roberts D.L., Harris R.R., Zhang X.F., Shieh C.C., Wismer C.T., Zhu C.Z., Gauvin D.M., Fabiyi A.C., Honore P., Gregg R.J., Kort M.E., Nelson D.W., Carroll W.A., Marsh K., Faltynek C.R., Jarvis M.F. P2X7-related modulation of pathological nociception in rats. Neuroscience 2007, 146:1817-1828.
65. Miller G. Neuroscience. The dark side of glia. Science 2005, 308:778-781.
66. Nagata K., Imai T., Yamashita T., Tsuda M., Tozaki-Saitoh H., Inoue K. Antidepressants inhibit P2X4 receptor function: a possible involvement in neuropathic pain relief. Mol. Pain 2009, 5:20.
67. Nakazawa K., Inoue K., Ito K., Koizumi S. Inhibition by suramin and reactive blue 2 of GABA and glutamate receptor channels in rat hippocampal neurons. Naunyn Schmiedebergs Arch. Pharmacol. 1995, 351:202-208.
68. Nasu-Tada K., Koizumi S., Tsuda M., Kunifusa E., Inoue K. Possible involvement of increase in spinal fibronectin following peripheral nerve injury in upregulation of microglial P2X(4), a key molecule for mechanical allodynia. Glia 2006, 53:769-775.
69. Nicke A., Baumert H.G., Rettinger J., Eichele A., Lambrecht G., Mutschler E., Schmalzing G. P2X1 and P2X3 receptors form stable trimers: a novel structural motif of ligand-gated ion channels. EMBO J. 1998, 17:3016-3028.
70. Nicke A., Rettinger J., Schmalzing G. Monomeric and dimeric byproducts are the principal functional elements of higher order P2X1 concatamers. Mol. Pharmacol. 2003, 63:243-252.
71. Nicke A. Homotrimeric complexes are the dominant assembly state of native P2X7 subunits. Biochem. Biophys. Res. Commun. 2008, 377:803-808.
72. Nishida M., Sato Y., Uemura A., Narita Y., Tozaki-Saitoh H., Nakaya M., Ide T., Suzuki K., Inoue K., Nagao T., Kurose H. P2Y6 receptor-Galpha12/13 signalling in cardiomyocytes triggers pressure overload-induced cardiac fibrosis. EMBO J. 2008, 27:3104-3115.
73. North R.A. Molecular physiology of P2X receptors. Physiol. Rev. 2002, 82:1013-1067.
74. Obata K., Katsura H., Mizushima T., Sakurai J., Kobayashi K., Yamanaka H., Dai Y., Fukuoka T., Noguchi K. Roles of extracellular signal-regulated protein kinases 5 in spinal microglia and primary sensory neurons for neuropathic pain. J. Neurochem. 2007, 102:1569-1584.
75. Ohsawa K., Irino Y., Nakamura Y., Akazawa C., Inoue K., Kohsaka S. Involvement of P2X(4) and P2Y(12) receptors in ATP-induced microglial chemotaxis. Glia 2007, 55:604-616.
76. Pausch M.H., Lai M., Tseng E., Paulsen J., Bates B., Kwak S. Functional expression of human and mouse P2Y12 receptors in Saccharomyces cerevisiae. Biochem. Biophys. Res. Commun. 2004, 324:171-177.
77. Peoples R.W., Li C. Inhibition of NMDA-gated ion channels by the P2 purinoceptor antagonists suramin and reactive blue 2 in mouse hippocampal neurones. Br. J. Pharmacol. 1998, 124:400-408.
78. Qureshi O.S., Paramasivam A., Yu J.C., Murrell-Lagnado R.D. Regulation of P2X4 receptors by lysosomal targeting, glycan protection and exocytosis. J. Cell. Sci. 2007, 120:3838-3849.
79. Ralevic V., Burnstock G. Receptors for purines and pyrimidines. Pharmacol. Rev. 1998, 50:413-492.
80. Reeve A.J., Patel S., Fox A., Walker K., Urban L. Intrathecally administered endotoxin or cytokines produce allodynia, hyperalgesia and changes in spinal cord neuronal responses to nociceptive stimuli in the rat. Eur. J. Pain 2000, 4:247-257.
81. Salter M.W., Hicks J.L. ATP-evoked increases in intracellular calcium in neurons and glia from the dorsal spinal cord. J. Neurosci. 1994, 14:1563-1575.
82. Sasaki Y., Hoshi M., Akazawa C., Nakamura Y., Tsuzuki H., Inoue K., Kohsaka S. Selective expression of Gi/o-coupled ATP receptor P2Y12 in microglia in rat brain. Glia 2003, 44,:242-250.
83. Savi P., Herbert J.M. Clopidogrel and ticlopidine: P2Y12 adenosine diphosphate-receptor antagonists for the prevention of atherothrombosis. Semin. Thromb. Hemost. 2005, 31:174-183.
84. Scholz J., Woolf C.J. Can we conquer pain?. Nat. Neurosci. 2002, 5 Suppl:1062-1067.
85. Scholz J., Woolf C.J. The neuropathic pain triad: neurons, immune cells and glia. Nat. Neurosci. 2007, 10:1361-1368.
86. Shinozaki Y., Sumitomo K., Tsuda M., Koizumi S., Inoue K., Torimitsu K. Direct observation of ATP-induced conformational changes in single P2X4 receptors. PLoS Biol. 2009, e103:7.
87. Stokes L., Jiang L.H., Alcaraz L., Bent J., Bowers K., Fagura M., Furber M., Mortimore M., Lawson M., Theaker J., Laurent C., Braddock M., Surprenant A. Characterization of a selective and potent antagonist of human P2X(7) receptors, AZ11645373. Br. J. Pharmacol. 2006, 149:880-887.
88. Stoop R., Thomas S., Rassendren F., Kawashima E., Buell G., Surprenant A., North R.A. Contribution of individual subunits to the multimeric P2X(2) receptor: estimates based on methanethiosulfonate block at T336C. Mol. Pharmacol. 1999, 56:973-981.
89. Suter M.R., Wen Y.R., Decosterd I., Ji R.R. Do glial cells control pain?. Neuron Glia Biol. 2007, 3:255-268.
90. Tanga F.Y., Nutile-McMenemy N., DeLeo J.A. The CNS role of Toll-like receptor 4 in innate neuroimmunity and painful neuropathy. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:5856-5861.
91. Torres G.E., Haines W.R., Egan T.M., Voigt M.M. Co-expression of P2X1 and P2X5 receptor subunits reveals a novel ATP-gated ion channel. Mol. Pharmacol. 1998, 54:989-993.
92. Tozaki-Saitoh H., Tsuda M., Miyata H., Ueda K., Kohsaka S., Inoue K. P2Y12 receptors in spinal microglia are required for neuropathic pain after peripheral nerve injury. J. Neurosci. 2008, 28:4949-4956.
93. Trang T., Beggs S., Wan X., Salter M.W. P2X4-receptor-mediated synthesis and release of brain-derived neurotrophic factor in microglia is dependent on calcium and p38-mitogen-activated protein kinase activation. J. Neurosci. 2009, 29:3518-3528.
94. Tsuda M., Shigemoto-Mogami Y., Koizumi S., Mizokoshi A., Kohsaka S., Salter M.W., Inoue K. P2X4 receptors induced in spinal microglia gate tactile allodynia after nerve injury. Nature 2003, 424:778-783.
95. Tsuda M., Mizokoshi A., Shigemoto-Mogami Y., Koizumi S., Inoue K. Activation of p38 mitogen-activated protein kinase in spinal hyperactive microglia contributes to pain hypersensitivity following peripheral nerve injury. Glia 2004, 45:89-95.
96. Tsuda M., Inoue K., Salter M.W. Neuropathic pain and spinal microglia: a big problem from molecules in ″ small″ glia. Trends Neurosci. 2005, 28:101-107.
97. Tsuda M., Toyomitsu E., Komatsu T., Masuda T., Kunifusa E., Nasu-Tada K., Koizumi S., Yamamoto K., Ando J., Inoue K. Fibronectin/integrin system is involved in P2X(4) receptor upregulation in the spinal cord and neuropathic pain after nerve injury. Glia 2008, 56:579-585.
98. Tsuda M., Tozaki-Saitoh H., Masuda T., Toyomitsu E., Tezuka T., Yamamoto T., Inoue K. Lyn tyrosine kinase is required for P2X(4) receptor upregulation and neuropathic pain after peripheral nerve injury. Glia 2008, 56:50-58.
99. Tsuda M., Kuboyama K., Inoue T., Nagata K., Tozaki-Saitoh H., Inoue K. Behavioral phenotypes of mice lacking purinergic P2X4 receptors in acute and chronic pain assays. Mol. Pain 2009, 5:28.
100. Tsuda M., Toyomitsu E., Kometani M., Tozaki-Saitoh H., Inoue K. Mechanisms underlying fibronectin-induced upregulation of P2X4R expression in microglia: distinct roles of PI3K-Akt and MEK-ERK signaling pathways. J. Cell. Mol. Med. 2010, 13:3251-3259.
101. Ulmann L., Hatcher J.P., Hughes J.P., Chaumont S., Green P.J., Conquet F., Buell G.N., Reeve A.J., Chessell I.P., Rassendren F. Up-regulation of P2X4 receptors in spinal microglia after peripheral nerve injury mediates BDNF release and neuropathic pain. J. Neurosci. 2008, 28:11263-11268.
102. Vial C., Roberts J.A., Evans R.J. Molecular properties of ATP-gated P2X receptor ion channels. Trends Pharmacol. Sci. 2004, 25:487-493.
103. Virginio C., Robertson G., Surprenant A., North R.A. Trinitrophenyl-substituted nucleotides are potent antagonists selective for P2X1, P2X3, and heteromeric P2X2/3 receptors. Mol. Pharmacol. 1998, 53:969-973.
104. Viviani B., Bartesaghi S., Gardoni F., Vezzani A., Behrens M.M., Bartfai T., Binaglia M., Corsini E., Di Luca M., Galli C.L., Marinovich M. Interleukin-1beta enhances NMDA receptor-mediated intracellular calcium increase through activation of the Src family of kinases. J. Neurosci. 2003, 23:8692-8700.
105. Wang S., Cheng Q., Malik S., Yang J. Interleukin-1beta inhibits gamma-aminobutyric acid type A (GABA(A)) receptor current in cultured hippocampal neurons. J. Pharmacol. Exp. Ther. 2000, 292:497-504.
106. Watkins L.R., Milligan E.D., Maier S.F. Glial activation: a driving force for pathological pain. Trends Neurosci. 2001, 24:450-455.
107. Webb T.E., Simon J., Krishek B.J., Bateson A.N., Smart T.G., King B.F., Burnstock G., Barnard E.A. Cloning and functional expression of a brain G-protein-coupled ATP receptor. FEBS Lett. 1993, 324:219-225.
108. Wilkinson W.J., Jiang L.H., Surprenant A., North R.A. Role of ectodomain lysines in the subunits of the heteromeric P2X2/3 receptor. Mol. Pharmacol. 2006, 70:1159-1163.
109. Wirkner K., Stanchev D., Koles L., Klebingat M., Dihazi H., Flehmig G., Vial C., Evans R.J., Furst S., Mager P.P., Eschrich K., Illes P. Regulation of human recombinant P2X3 receptors by ecto-protein kinase C. J. Neurosci. 2005, 25:7734-7742.
110. Woolf C.J., Mannion R.J. Neuropathic pain: aetiology, symptoms, mechanisms, and management. Lancet 1999, 353:1959-1964.
111. Woolf C.J., Salter M.W. Neuronal plasticity: increasing the gain in pain. Science 2000, 288:1765-1769.
112. Zhao P., Waxman S.G., Hains B.C. Extracellular signal-regulated kinase-regulated microglia-neuron signaling by prostaglandin E2 contributes to pain after spinal cord injury. J. Neurosci. 2007, 27:2357-2368.
113. Zhuang Z.Y., Gerner P., Woolf C.J., Ji R.R. ERK is sequentially activated in neurons, microglia, and astrocytes by spinal nerve ligation and contributes to mechanical allodynia in this neuropathic pain model. Pain 2005, 114:149-159.
114. Zhuang Z.Y., Wen Y.R., Zhang D.R., Borsello T., Bonny C., Strichartz G.R., Decosterd I., Ji R.R. A peptide c-Jun N-terminal kinase (JNK) inhibitor blocks mechanical allodynia after spinal nerve ligation: respective roles of JNK activation in primary sensory neurons and spinal astrocytes for neuropathic pain development and maintenance. J. Neurosci. 2006, 26:3551-3560.